静脉曲张治疗市场规模、份额和成长分析：按类型、产品、最终用途和地区 - 2024-2031 年行业预测

静脉曲张治疗市场规模预计2023年为13.8亿美元，从2024年的14.7亿美元成长到2032年的24亿美元，复合年增长率预计将成长6.32%。

全球静脉曲张治疗市场经历了显着增长，随着人口老化、久坐的生活方式和肥胖增加了这种常见疾病的盛行率，预计将继续扩大。市场正在转向微创治疗，如内源性雷射消熔、硬化疗法和射频消融术，与传统手术相比，这些治疗具有减轻疼痛和加速恢復时间等优点。最近的技术进步，包括超音波导引的泡沫硬化疗法，改善了患者的治疗效果和满意度。然而，报销问题、高昂的治疗费用和认识不足等挑战可能会限制可及性，特别是在发展中地区。随着公司专注于创新，竞争格局正在加剧，需要持续投资于研究和监管合规性，以有效地将新解决方案推向市场。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 价格分析

按类型分類的静脉曲张治疗市场规模

• 市场概况
• 静脉消融
  • 静脉雷射治疗
  • 射频消融术
• 注射硬化疗法
• 手术结扎和剥离

静脉曲张治疗市场规模：依产品

• 市场概况
• 消融装置
• 射频消融术装置
• 雷射消熔装置
• 静脉缝合产品

以最终用途分類的静脉曲张治疗市场规模

• 市场概况
• 医院
• 门诊手术中心
• 专科诊所

静脉曲张治疗市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Medtronic plc（Ireland）
• AngioDynamics, Inc.（USA）
• Teleflex Incorporated（USA）
• Boston Scientific Corporation（USA）
• Lumenis Ltd.（Israel）
• Quanta System SpA（Italy）
• Biolitec AG（Austria）
• Dornier MedTech GmbH（Germany）
• Sciton, Inc.（USA）
• Fotona doo（Slovenia）
• Viatris Inc.（USA）
• Merz Aesthetics（USA）
• SIGVARIS Group（Switzerland）
• Essity Aktiebolag（publ）（Sweden）
• F Care Systems NV（Belgium）
• VVT Medical（Israel）
• Alma Lasers（Israel）
• Energist Group（UK）.
• Eufoton srl（Italy）
• WONTECH Co., Ltd.（South Korea）

结论和建议

Varicose Veins Treatment Market size was valued at USD 1.38 Billion in 2023 and is poised to grow from USD 1.47 Billion in 2024 to USD 2.4 Billion by 2032, growing at a CAGR of 6.32% during the forecast period (2025-2032).

The global varicose veins treatment market is witnessing remarkable growth and is projected to continue its expansion due to the increasing prevalence of this common condition, spurred by an aging population, sedentary lifestyles, and obesity. The market is shifting towards minimally invasive treatments like endogenous laser ablation, sclerotherapy, and radiofrequency ablation, which offer benefits such as reduced pain and shorter recovery times compared to traditional surgery. Recent technological advancements, including ultrasound-guided foam sclerotherapy, are enhancing patient outcomes and satisfaction. However, challenges such as reimbursement issues, high treatment costs, and inadequate awareness can limit accessibility, particularly in developing regions. The competitive landscape is intensifying as companies focus on innovation, necessitating ongoing investment in research and regulatory compliance to bring new solutions to market effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Varicose Veins Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Varicose Veins Treatment Market Segmental Analysis

Global Varicose Veins Treatment Market is segmented by type, products, end use and region. Based on type, the market is segmented into endovenous ablation, injection sclerotherapy and surgical ligation & stripping. Based on products, the market is segmented into ablation devices, radiofrequency ablation devices, laser ablation devices and venous closure products. Based on end use, the market is segmented into hospitals, ambulatory surgical centers and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Varicose Veins Treatment Market

The Varicose Veins Treatment market is being propelled by a surge in awareness and education concerning varicose veins and the treatment options available. With public awareness campaigns, educational initiatives, and the widespread dissemination of information through various platforms, more individuals are becoming informed about their conditions. This increased knowledge empowers patients to take action and seek appropriate treatment for their varicose veins. As a result, the combination of heightened awareness and patient education is fostering a growing demand in the market, leading to an increase in the number of individuals pursuing effective treatment solutions to address their varicose vein issues.

Restraints in the Varicose Veins Treatment Market

The varicose veins treatment market faces significant restraints due to regulatory challenges. Manufacturers must navigate complex regulatory requirements and approval processes, which can vary widely across different countries. This intricacy can lead to delays and increased costs, hampering the timely introduction of new treatments and innovations. Consequently, the burden of regulatory compliance may deter companies from pursuing advancements in the field, ultimately limiting options for patients seeking effective solutions. As a result, the overall growth and development of the varicose veins treatment market may be adversely impacted, creating obstacles for both manufacturers and healthcare providers alike.

Market Trends of the Varicose Veins Treatment Market

The varicose veins treatment market is experiencing a significant shift towards combination therapies, which are becoming increasingly popular due to their ability to optimize treatment outcomes. Combining modalities like endovenous ablation with sclerotherapy allows for a comprehensive approach, effectively targeting various facets of venous disease. This trend not only enhances the efficacy of treatments but also boosts patient satisfaction, leading to a more favorable perception of varicose vein options. As healthcare providers look to maximize results and improve the overall patient experience, the adoption of combination therapies is expected to drive market growth and innovation in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Varicose Veins Treatment Market Size by Type & CAGR (2025-2032)

• Market Overview
• Endovenous Ablation
  • Endovenous Laser Therapy
  • Radiofrequency Ablation
• Injection Sclerotherapy
• Surgical Ligation & Stripping

Global Varicose Veins Treatment Market Size by Products & CAGR (2025-2032)

• Market Overview
• Ablation Devices
• Radiofrequency Ablation Devices
• Laser Ablation Devices
• Venous Closure Products

Global Varicose Veins Treatment Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Varicose Veins Treatment Market Size & CAGR (2025-2032)

• North America (Type, Products, End Use)
  • US
  • Canada
• Europe (Type, Products, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Products, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Products, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Products, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lumenis Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quanta System S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolitec AG (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dornier MedTech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sciton, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fotona d.o.o. (Slovenia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Aesthetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIGVARIS Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Essity Aktiebolag (publ) (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F Care Systems NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VVT Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alma Lasers (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Energist Group (UK).
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eufoton s.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WONTECH Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations